Literature DB >> 7550814

Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care.

D A Clements1, L Langdon, C Bland, E Walter.   

Abstract

OBJECTIVE: To determine if the use of influenza vaccine in children in day care decreases the incidence of otitis media during the influenza season.
DESIGN: Prospective cohort study.
SETTING: Eight day-care centers in North Carolina. PARTICIPANTS: One hundred eighty-six children aged 6 to 30 months. INTERVENTION: Half the participants received trivalent subvirion influenza virus vaccine. MEASUREMENTS: Acute otitis media (AOM) and serous otitis media (SOM) were assessed biweekly from mid-November 1993 to mid-March 1994 by visual and tympanometric examinations performed by "blinded" observers. The winter season was divided into three periods-before, during, and after influenza season--and the number of children with AOM or SOM during each period was determined. Unadjusted and adjusted odds ratios (ORs) were computed, while controlling for race and sex using logistic regression methods.
RESULTS: Influenza vaccine was protective against AOM (OR = 0.69, 95% CI, 0.49-0.98) during the influenza season. Although there may have been some protection against SOM (OR = 0.75, 95% CI, 0.54-1.02) statistical significance was not achieved. Myringotomy tubes were also significantly protective against AOM and SOM during all three time periods, with ORs between 0.34 and 0.52, but the greatest protection was seen during the influenza period.
CONCLUSIONS: Influenza vaccination of 6- to 30-month-old children in day care was associated with a decreased incidence of otitis media during the influenza season. Myringotomy tubes protected against AOM and SOM during all 16 weeks monitored.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550814     DOI: 10.1001/archpedi.1995.02170230067009

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  57 in total

1.  Is antimicrobial therapy of value for all children with acute otitis media?

Authors:  J O Klein
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

Review 2.  Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.

Authors:  S L Block
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

3.  Do we need to treat otitis media?

Authors:  S Chaudhary
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

4.  Complications of Acute Otitis Media and Sinusitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

5.  Management of acute otitis media.

Authors:  S Forgie; G Zhanel; J Robinson
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

Review 6.  Recent developments in the treatment of otitis media with effusion.

Authors:  Ellen M Mandel; Margaretha L Casselbrant
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Authors:  Irina V Alymova; Allen Portner; Toru Takimoto; Kelli L Boyd; Y Sudhakara Babu; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

Authors:  Terho Heikkinen; Robert Booy; Magda Campins; Adam Finn; Per Olcén; Heikki Peltola; Carlos Rodrigo; Heinz-Josef Schmitt; Fabian Schumacher; Stephen Teo; Catherine Weil-Olivier
Journal:  Eur J Pediatr       Date:  2005-12-21       Impact factor: 3.183

9.  Universal influenza immunization. Were Ontario family physicians prepared?

Authors:  Grant Russell; Judy Sutton; Graham J Reid; Charlene Beynon; Irene Cohen; David Huffman
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

Review 10.  Role of influenza vaccine for healthy children in the US.

Authors:  Stan L Block
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.